Kindstar Globalgene Technology, Inc. disclosed on 17 June 2026 that it bought back 0.01 million ordinary shares (8,000 shares) on the Hong Kong Stock Exchange under its share-repurchase mandate.

The shares were acquired at prices between HKD 0.98 and HKD 1.00, with a volume-weighted average cost of HKD 0.99 per share and a total consideration of HKD 7,884.80.

Post-transaction, the number of issued shares (excluding treasury stock) fell 0.00077 % to 1.03 billion, while treasury shares increased to 7.23 million. Total issued shares remain at 1.04 billion.

The buyback forms part of the mandate approved on 05 June 2026, which authorises the repurchase of up to 103.43 million shares. Cumulative purchases under this mandate now stand at 0.17 million shares, equivalent to 0.0162 % of the company’s share base on the mandate date.

A moratorium on any new share issuance or sale of treasury shares is in effect until 17 July 2026, in accordance with Hong Kong listing rules.